டேவிட் பார்தெல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Landscape Show Returns to Orlando for Big 2021 Show : CEG
constructionequipmentguide.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from constructionequipmentguide.com Daily Mail and Mail on Sunday newspapers.
Health Logic Interactive Signs Non-Binding Letter of Intent With US Medical Device Company to Sell Wholly Owned Operating Subsidiary
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Lakes Area Artists to hold exhibit, sale July 2-3 | Pine and Lakes Echo Journal
pineandlakes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pineandlakes.com Daily Mail and Mail on Sunday newspapers.
Health Logic Interactive Announces Proof-of-Concept Test Results and Advancement of its Lab-on-Chip Technology
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Health Logic Interactive Announces Appointment of Scientific Advisory Board Members and First Virtual Meeting
News provided by
Share this article
Health Logic Interactive Inc. (
Health Logic or the
Company ) (TSXV: CHIP.H) (OTCPK: CHYPF) is pleased to announce the addition of new members to its Scientific Advisory Board (
SAB ) including nephrology specialists Dr. Adeera Levin from the University of British Columbia, Dr. Lesley Inker of Tufts Medical Center, and Dr. Susan Quaggin of Northwestern University.
Drs. Levin, Inker and Quaggin have a wealth of experience in chronic kidney disease (
CKD ) research including numerous peer-reviewed publications and awards. Management believes that the advice and direction of the SAB, including the new members, will be crucial as the Company looks to obtain the approval of the United States Federal Drug Administration (